Fortrea Holdings (FTRE) Accounts Payables (2022 - 2026)

Fortrea Holdings (FTRE) posted Accounts Payables of $70.8 million for Q1 2026, up 138.38% on a QoQ basis from $29.7 million in Q4 2025, and down 35.75% year-over-year from $110.2 million in Q1 2025.

Fortrea Holdings (FTRE) Accounts Payables (2022 - 2026) Analysis & Trends

Fortrea Holdings' Accounts Payables history runs 5 years deep, the most recent figure standing at $70.8 million for Q1 2026.

  • Quarterly Accounts Payables fell 35.75% year-over-year to $70.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $70.8 million (down 35.75% YoY) and the FY2025 annual result came in at $29.7 million, down 78.51% from the prior year.
  • Accounts Payables was $70.8 million for Q1 2026 at Fortrea Holdings, up from $29.7 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $144.2 million in Q2 2024 and bottomed at $29.7 million in Q4 2025.
  • A 5-year average of $104.0 million and a median of $110.2 million in 2025 frame the typical range for Accounts Payables.
  • Annual changes were most pronounced in 2023 — Accounts Payables jumped 63.07% — and 2025, when it plunged 78.51%.
  • Fortrea Holdings' Accounts Payables stood at $81.5 million in 2022, then soared by 63.07% to $132.9 million in 2023, then advanced by 3.99% to $138.2 million in 2024, then plunged by 78.51% to $29.7 million in 2025, then jumped by 138.38% to $70.8 million in 2026.
  • Business Quant data shows FTRE's Accounts Payables at $70.8 million in Q1 2026, $29.7 million in Q4 2025, and $49.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Oculis Holding AG 67,102.16 Bn 67,101.87 Bn - 5.74 Mn
2 Nanobiotix 1,908.96 Bn 1,908.90 Bn - 10.62 Mn
3 Akari Therapeutics 959.56 Bn 959.56 Bn - 8.64 Mn
4 BeOne Medicines 474.03 Bn 469.24 Bn 1.35 Bn 423.55 Mn
5 Vertex Pharmaceuticals 122.13 Bn 114.88 Bn 2.59 Bn 489.30 Mn
6 Regeneron Pharmaceuticals 70.09 Bn 61.34 Bn 3.31 Bn 1.03 Bn
7 Belite Bio 62.34 Bn 62.34 Bn - -
8 Argenx Se 55.96 Bn 50.77 Bn 1.41 Bn 1.52 Bn
9 Alnylam Pharmaceuticals 37.53 Bn 34.52 Bn 959.66 Mn 126.63 Mn
10 Fortrea Holdings 1.83 Bn 1.68 Bn 123.60 Mn 70.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 70.80 Mn
Dec 31, 2025 29.70 Mn
Sep 30, 2025 49.50 Mn
Jun 30, 2025 92.60 Mn
Mar 31, 2025 110.20 Mn
Dec 31, 2024 138.20 Mn
Sep 30, 2024 137.60 Mn
Jun 30, 2024 144.20 Mn
Mar 31, 2024 131.30 Mn
Dec 31, 2023 132.90 Mn
Sep 30, 2023 128.30 Mn
Jun 30, 2023 105.30 Mn
Dec 31, 2022 81.50 Mn